XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED STATEMENTS OF REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Series B1 Redeemable Convertible Preferred Stock
Total
Beginning balance at Dec. 31, 2020 $ 38 $ 742,342 $ (833,552)   $ (91,172)
Beginning balance (in shares) at Dec. 31, 2020 38,291,000     24,000  
Sale of common stock, net of issuance costs $ 3 16,258     16,261
Sale of common stock, net of issuance costs (in shares) 3,195,000        
Conversion of Series B1 preferred stock $ 1 (1)      
Conversion of Series B1 preferred stock (in shares) 1,415,000     (14,000)  
Issuance of common stock under employee stock purchase plan   28     28
Issuance of common stock under employee stock purchase plan (in shares) 8,000        
Issuance of common stock under equity incentive plan (vesting of restricted stock units) (in shares) 237,000        
Issuance of common stock upon exercise of common stock options and warrants $ 4 267     271
Issuance of common stock upon exercise of common stock options and warrants (in shares) 3,375,000        
Issuance of common stock for services rendered   67     67
Issuance of common stock for services rendered (in shares) 16,000        
Stock-based compensation expense   1,111     1,111
Net income (loss)     115,738   115,738
Ending balance at Mar. 31, 2021 $ 46 760,072 (717,814)   42,304
Ending balance (in shares) at Mar. 31, 2021 46,537,000     10,000  
Beginning balance at Dec. 31, 2020 $ 38 742,342 (833,552)   (91,172)
Beginning balance (in shares) at Dec. 31, 2020 38,291,000     24,000  
Conversion of Series B1 preferred stock (in shares)       (23,684)  
Net income (loss)         108,175
Ending balance at Jun. 30, 2021 $ 52 763,051 (725,377)   37,726
Ending balance (in shares) at Jun. 30, 2021 52,115,000        
Beginning balance at Mar. 31, 2021 $ 46 760,072 (717,814)   42,304
Beginning balance (in shares) at Mar. 31, 2021 46,537,000     10,000  
Sale of common stock, net of issuance costs $ 2 2,510     2,512
Sale of common stock, net of issuance costs (in shares) 2,076,000        
Conversion of Series B1 preferred stock $ 1 (1)      
Conversion of Series B1 preferred stock (in shares) 953,000     (10,000)  
Issuance of common stock under employee stock purchase plan   6     6
Issuance of common stock under employee stock purchase plan (in shares) 6,000        
Issuance of common stock upon exercise of common stock options and warrants $ 3 (3)      
Issuance of common stock upon exercise of common stock options and warrants (in shares) 2,496,000        
Issuance of common stock for services rendered   63     63
Issuance of common stock for services rendered (in shares) 47,000        
Stock-based compensation expense   404     404
Net income (loss)     (7,563)   (7,563)
Ending balance at Jun. 30, 2021 $ 52 763,051 (725,377)   37,726
Ending balance (in shares) at Jun. 30, 2021 52,115,000        
Beginning balance at Dec. 31, 2021 $ 53 764,861 (735,461)   $ 29,453
Beginning balance (in shares) at Dec. 31, 2021 52,818,000       52,818,000
Sale of common stock, net of issuance costs   (15)     $ (15)
Issuance of common stock under employee stock purchase plan   16     16
Issuance of common stock under employee stock purchase plan (in shares) 42,000        
Issuance of common stock under equity incentive plan (vesting of restricted stock units) (in shares) 27,000        
Issuance of common stock for services rendered   22     22
Issuance of common stock for services rendered (in shares) 37,000        
Stock-based compensation expense   545     545
Net income (loss)     (4,178)   (4,178)
Ending balance at Mar. 31, 2022 $ 53 765,429 (739,639)   25,843
Ending balance (in shares) at Mar. 31, 2022 52,924,000        
Beginning balance at Dec. 31, 2021 $ 53 764,861 (735,461)   $ 29,453
Beginning balance (in shares) at Dec. 31, 2021 52,818,000       52,818,000
Net income (loss)         $ (9,485)
Ending balance at Jun. 30, 2022 $ 53 766,025 (744,946)   $ 21,132
Ending balance (in shares) at Jun. 30, 2022 52,999,000       52,999,000
Beginning balance at Mar. 31, 2022 $ 53 765,429 (739,639)   $ 25,843
Beginning balance (in shares) at Mar. 31, 2022 52,924,000        
Issuance of common stock under employee stock purchase plan   12     12
Issuance of common stock under employee stock purchase plan (in shares) 34,000        
Issuance of common stock for services rendered   22     22
Issuance of common stock for services rendered (in shares) 41,000        
Stock-based compensation expense   562     562
Net income (loss)     (5,307)   (5,307)
Ending balance at Jun. 30, 2022 $ 53 $ 766,025 $ (744,946)   $ 21,132
Ending balance (in shares) at Jun. 30, 2022 52,999,000       52,999,000